Liquidia Technologies Inc (LQDA)
Healthcare
Drug Manufacturers - Specialty & Generic
83.90 $
-0.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Liquidia Technologies Inc (LQDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -36 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -14 | -24 | -32 | -48 | -54 | -34 | -29 | -42 | -93 | -36 | |
| 0.7 | 0.9 | 1.5 | 2.6 | 3.1 | 5.6 | 3.6 | 2.2 | 2.2 | 1.5 | |
| 0.3 | 0.5 | 2.2 | 3.4 | 4.0 | 6.7 | 9.3 | 10 | 19 | 29 | |
| 0.7 | -6.3 | 1.9 | 3.4 | 4.1 | 7.3 | 11 | – | – | – | |
| 0.6 | 0.4 | 0.3 | -7.0 | -1.7 | -12 | -2.2 | 5.9 | -4.8 | -24 | |
| 2.9 | 2.5 | 0.9 | 1.9 | 0.8 | 0.1 | 0.6 | 1.3 | 4.9 | 4.3 | |
| -2.9 | -2.5 | -0.9 | -1.9 | 0.2 | -0.1 | -0.6 | -11 | -8.4 | -6.3 | |
| 0.4 | 0.1 | 73 | 62 | – | – | – | – | – | – | |
| 5.7 | 30 | -1.4 | 4.0 | -6.8 | -0.4 | 9.0 | 18 | 53 | 54 | |
| 6.1 | 29 | 69 | 66 | 63 | 26 | 65 | 43 | 195 | 60 | |
| -11 | 2.0 | 36 | 16 | 9.5 | -7.8 | 36 | -9.6 | 93 | 14 | |
| -17 | -27 | -33 | -50 | -55 | -34 | -29 | -43 | -98 | -40 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.